New resource available view now
New resource available view now
Recent Post
Related Posts
Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer’s discovery and clinical development
Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than $552,362 of personal cash previously advanced to IGC
Patent-pending multi-agent architecture targets fragmented biomedical data and expands toward imaging, omics, and broader health-data applications ahead of planned AAIC 2026 demonstration in London
Psilocybin, a psychedelic compound in “magic mushrooms,” has shown potential in treating refractory depression, addiction, and terminal cancer-related anxiety. Although early studies show promising results, further research is needed to
Company continuing limited over-enrollment activities to account for attrition and support robust modified intent-to-treat, end-of-treatment, and exploratory analyses